Production will begin in December and the vaccine will be exported to countries around the world starting in January 2021. The first interim results of a large-scale Phase III clinical trial for the jab were released earlier this week and showed 92-percent efficacy. Researchers said they would publish their preliminary findings in …
Read More »Russia deals with South Korean pharmaceutical GL Rapha to manufacture Sputnik V coronavirus vaccine
